JP2025090723A5 - - Google Patents
Info
- Publication number
- JP2025090723A5 JP2025090723A5 JP2025038216A JP2025038216A JP2025090723A5 JP 2025090723 A5 JP2025090723 A5 JP 2025090723A5 JP 2025038216 A JP2025038216 A JP 2025038216A JP 2025038216 A JP2025038216 A JP 2025038216A JP 2025090723 A5 JP2025090723 A5 JP 2025090723A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- cancer
- lipid
- peg
- sting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962913035P | 2019-10-09 | 2019-10-09 | |
| US62/913,035 | 2019-10-09 | ||
| JP2022521307A JP7650873B2 (ja) | 2019-10-09 | 2020-10-09 | メッセンジャーrnaの組成物、方法および使用 |
| PCT/US2020/054952 WO2021072172A1 (en) | 2019-10-09 | 2020-10-09 | Compositions, methods and uses of messenger rna |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022521307A Division JP7650873B2 (ja) | 2019-10-09 | 2020-10-09 | メッセンジャーrnaの組成物、方法および使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025090723A JP2025090723A (ja) | 2025-06-17 |
| JP2025090723A5 true JP2025090723A5 (cg-RX-API-DMAC7.html) | 2025-09-08 |
Family
ID=73040270
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022521307A Active JP7650873B2 (ja) | 2019-10-09 | 2020-10-09 | メッセンジャーrnaの組成物、方法および使用 |
| JP2025038216A Pending JP2025090723A (ja) | 2019-10-09 | 2025-03-11 | メッセンジャーrnaの組成物、方法および使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022521307A Active JP7650873B2 (ja) | 2019-10-09 | 2020-10-09 | メッセンジャーrnaの組成物、方法および使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US12076438B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4529928A3 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7650873B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN114728176B (cg-RX-API-DMAC7.html) |
| ES (1) | ES3028783T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021072172A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2023004299A (es) * | 2020-10-13 | 2023-07-07 | Univ Pennsylvania | Direccionamiento de células t cd4+ in vivo para terapeuticos de arnm. |
| CN115960906A (zh) * | 2022-05-07 | 2023-04-14 | 苏州科锐迈德生物医药科技有限公司 | 用于抗肿瘤免疫治疗的rna组合物、rna制剂及用途 |
| WO2024164006A2 (en) * | 2023-02-03 | 2024-08-08 | The Regents Of The University Of California | Self-amplifying rna form of a constitutively-active sting protein for enhancing t-cell response to antigenpresenting cells |
| WO2024240962A1 (en) * | 2023-05-25 | 2024-11-28 | Ethris Gmbh | Gm-csf-encoding nucleic acids, pharmaceutical compositions, methods and uses thereof |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4897355A (en) | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US4737323A (en) | 1986-02-13 | 1988-04-12 | Liposome Technology, Inc. | Liposome extrusion method |
| FR2645866B1 (fr) | 1989-04-17 | 1991-07-05 | Centre Nat Rech Scient | Nouvelles lipopolyamines, leur preparation et leur emploi |
| US5334761A (en) | 1992-08-28 | 1994-08-02 | Life Technologies, Inc. | Cationic lipids |
| US5885613A (en) | 1994-09-30 | 1999-03-23 | The University Of British Columbia | Bilayer stabilizing components and their use in forming programmable fusogenic liposomes |
| US5744335A (en) | 1995-09-19 | 1998-04-28 | Mirus Corporation | Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein |
| CA2569664C (en) | 2004-06-07 | 2013-07-16 | Protiva Biotherapeutics, Inc. | Lipid encapsulated interfering rna |
| PL2578685T3 (pl) | 2005-08-23 | 2020-01-31 | The Trustees Of The University Of Pennsylvania | Rna zawierający zmodyfikowane nukleozydy i sposoby jego zastosowania |
| AU2009303345B2 (en) | 2008-10-09 | 2015-08-20 | Arbutus Biopharma Corporation | Improved amino lipids and methods for the delivery of nucleic acids |
| WO2010053572A2 (en) | 2008-11-07 | 2010-05-14 | Massachusetts Institute Of Technology | Aminoalcohol lipidoids and uses thereof |
| EA022786B1 (ru) | 2009-07-31 | 2016-03-31 | Этрис Гмбх | Рнк с комбинацией из немодифицированных и модифицированных нуклеотидов для экспрессии белков |
| US8326547B2 (en) | 2009-10-07 | 2012-12-04 | Nanjingjinsirui Science & Technology Biology Corp. | Method of sequence optimization for improved recombinant protein expression using a particle swarm optimization algorithm |
| SI2506857T1 (en) | 2009-12-01 | 2018-08-31 | Translate Bio, Inc. | Delivery of mRNA for the enrichment of proteins and enzymes in human genetic diseases |
| EP4074693A1 (en) | 2011-06-08 | 2022-10-19 | Translate Bio, Inc. | Cleavable lipids |
| KR20220025112A (ko) | 2011-06-08 | 2022-03-03 | 샤이어 휴먼 지네틱 테라피즈 인크. | Mrna 전달을 위한 지질 나노입자 조성물 및 방법 |
| US9512073B2 (en) | 2011-10-27 | 2016-12-06 | Massachusetts Institute Of Technology | Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof |
| EA201492055A1 (ru) * | 2012-06-08 | 2015-11-30 | Шир Хьюман Дженетик Терапис, Инк. | ИНГАЛЯЦИОННАЯ ДОСТАВКА мРНК В НЕЛЕГОЧНЫЕ КЛЕТКИ-МИШЕНИ |
| EA201591229A1 (ru) | 2013-03-14 | 2016-01-29 | Шир Хьюман Дженетик Терапис, Инк. | Способы очистки матричной рнк |
| EA201591283A1 (ru) | 2013-03-14 | 2016-02-29 | Шир Хьюман Дженетик Терапис, Инк. | Количественная оценка эффективности кэп матричной рнк |
| ES3032935T3 (en) * | 2013-10-22 | 2025-07-29 | Translate Bio Inc | Lipid formulations for delivery of messenger rna |
| EP4729528A3 (en) | 2014-04-25 | 2026-06-24 | Translate Bio, Inc. | Methods for purification of messenger rna |
| AU2016251687C1 (en) * | 2015-04-22 | 2023-07-27 | CureVac SE | RNA containing composition for treatment of tumor diseases |
| RS63625B1 (sr) * | 2016-05-18 | 2022-10-31 | Modernatx Inc | Kombinacije irnk koje kodiraju imunomodulirajuće polipeptide i njihova upotreba |
| CA3042015A1 (en) * | 2016-10-26 | 2018-05-03 | Modernatx, Inc. | Messenger ribonucleic acids for enhancing immune responses and methods of use thereof |
| MX2019009070A (es) * | 2017-02-01 | 2019-10-30 | Modernatx Inc | Composiciones de arnm terapeuticas inmunomoduladoras que codifican peptidos de mutacion de oncogenes de activacion. |
| KR20240144261A (ko) | 2017-02-28 | 2024-10-02 | 사노피 | 치료적 rna |
| AU2018270111B2 (en) | 2017-05-18 | 2022-07-14 | Modernatx, Inc. | Polynucleotides encoding tethered interleukin-12 (IL12) polypeptides and uses thereof |
| TW202003032A (zh) | 2018-03-23 | 2020-01-16 | 美商科迪亞克生物科學公司 | 包含s t i n g 促效劑之胞外囊泡 |
| JP7256824B2 (ja) | 2018-04-25 | 2023-04-12 | エスリス ゲーエムベーハー | 粒子状製剤用の凍結保護剤 |
| EP3880174A2 (en) | 2018-11-12 | 2021-09-22 | Translate Bio, Inc. | Methods for inducing immune tolerance |
-
2020
- 2020-10-09 EP EP24217517.2A patent/EP4529928A3/en active Pending
- 2020-10-09 WO PCT/US2020/054952 patent/WO2021072172A1/en not_active Ceased
- 2020-10-09 ES ES20800417T patent/ES3028783T3/es active Active
- 2020-10-09 JP JP2022521307A patent/JP7650873B2/ja active Active
- 2020-10-09 CN CN202080082786.XA patent/CN114728176B/zh active Active
- 2020-10-09 EP EP20800417.6A patent/EP4041400B1/en active Active
- 2020-10-09 US US17/066,919 patent/US12076438B2/en active Active
-
2024
- 2024-07-24 US US18/782,767 patent/US20250057765A1/en active Pending
-
2025
- 2025-03-11 JP JP2025038216A patent/JP2025090723A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7744687B2 (ja) | CAR mRNA送達のための脂質ナノ粒子とその製剤 | |
| US12528855B2 (en) | KRAS variant mRNA molecules | |
| JP2025084968A5 (cg-RX-API-DMAC7.html) | ||
| Rietwyk et al. | Next-generation lipids in RNA interference therapeutics | |
| AU2004283464B2 (en) | Method of administering cationic liposomes comprising an active drug | |
| JP6077509B2 (ja) | 改良されたアミノ脂質および核酸の送達方法 | |
| JP2022552009A (ja) | 薬物送達のための脂質及び脂質ナノ粒子製剤 | |
| JP2022532213A5 (cg-RX-API-DMAC7.html) | ||
| US9827196B2 (en) | Method of administering a cationic liposomal preparation | |
| GB2600859A (en) | Improved lipid nanoparticles for delivery of nucleic acids | |
| JP2011507534A5 (cg-RX-API-DMAC7.html) | ||
| JP2017536092A5 (cg-RX-API-DMAC7.html) | ||
| JP2011529912A (ja) | 核酸送達システム用のナノ粒子組成物 | |
| HRP20180696T1 (hr) | ISPORUKA iRNK ZA POVEĆANJE EKSPRESIJE PROTEINA I ENZIMA U LJUDSKIM GENETSKIM BOLESTIMA | |
| JP2024535766A5 (cg-RX-API-DMAC7.html) | ||
| KR20250111222A (ko) | 신규 이온화 가능한 지질 및 이를 포함하는 지질나노입자 | |
| JP2020504138A5 (cg-RX-API-DMAC7.html) | ||
| RU2021119834A (ru) | МОЛЕКУЛЫ мРНК ВАРИАНТОВ KRAS | |
| US20250375502A1 (en) | Combination of il-12 and ox40l for cancer immunotherapy | |
| WO2025226959A1 (en) | Ionizable lipids and lipid nanoparticles and uses thereof |